Medical Product Development and Sales Expansion Leveraging Kakegawa Plant WEST
First written in FY2018. 3 of 6 entries say "Restated". Latest entry: FY2023.
0 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「In addition to our existing products, we will work to expand sales in the IT and automotive-related fields and to develop and expand sales of environmentally friendly products.」
The industrial materials business has stated its policy of continuing to expand sales in the IT and automotive-related fields and to develop and expand sales of environmentally friendly products. - FY2022AdvancedAnnual report
「In Industrial Materials, we have pursued initiatives in the medical and IT-related fields by leveraging the advanced equipment and high productivity of Kakegawa Plant WEST, as well as its clean environment. In addition to FPC-related applications, we are also working on development to meet new requirements in the 5G field.」
The company indicated that, in addition to medical and IT-related applications using Kakegawa Plant WEST, it was also working on development to meet new requirements related to 5G, broadening the fields addressed. - FY2021AdvancedAnnual report
「In particular, our efforts in the FPC-related field received high praise from users both in Japan and overseas.」
By expanding industrial materials into IT, medical, and other fields using the equipment and clean environment at Kakegawa Plant WEST, the company's FPC-related products received high praise from users in Japan and overseas. - FY2020RestatedAnnual report
「In the Industrial Materials segment, we aim to expand sales and improve customer satisfaction in terms of quality, cost, and delivery times by leveraging the high production capacity and clean environment of Kakegawa Plant WEST, established in June 2016.」
The company has reaffirmed its policy of using Kakegawa Plant WEST's production capacity and clean environment to improve quality, costs, and delivery times and expand sales. - FY2019RestatedAnnual report
「By leveraging Kakegawa Plant WEST's high production capacity and clean environment, we will improve customer satisfaction in terms of quality and delivery times, accelerate technological advancement and product development in the medical, IT-related, and carbon-fiber fields, where high profitability is expected, and transform our earnings structure.」
The company has reaffirmed its policy of using Kakegawa Plant WEST to develop and expand sales of products in the medical and other fields and transform its earnings structure. - FY2018First statedAnnual report
「By leveraging the clean environment at the newly established Kakegawa Plant WEST, we will promote product development and sales expansion in the medical field, expand production, and reduce manufacturing costs.」
The company presented the use of Kakegawa Plant WEST's clean environment to develop and expand sales of medical products and reduce costs through increased production as a new initiative.